Tag: Abbott Laboratories

A significant legal case commenced in Chicago on March 4, targeting global healthcare company Abbott Laboratories. The core of the ...

A significant legal challenge has been resolved in favor of Abbott Laboratories. This week, a U.S. federal court issued a ...

The healthcare giant Abbott Laboratories has taken a decisive step toward completing the largest acquisition in its corporate history. To ...

As Abbott Laboratories prepares to release its quarterly earnings, investor focus is split between a promising new product announcement and ...

Shares of medical device leader Abbott Laboratories opened the week on stable footing following a significant regulatory achievement. The company ...

Abbott Laboratories has announced an increase to its shareholder payout while simultaneously revealing mixed institutional trading activity. These developments coincide ...

Shares of Abbott Laboratories experienced significant volatility following the announcement of a major acquisition in the cancer diagnostics sector. The ...

While the broader healthcare sector contends with regulatory pressures and shifting post-pandemic dynamics, Abbott Laboratories continues to demonstrate notable resilience. ...

A significant regulatory milestone in Europe has positioned Abbott Laboratories for accelerated growth within its structural heart business. The medical ...

Abbott Laboratories continues to demonstrate remarkable operational resilience amid challenging market conditions. The healthcare conglomerate's latest quarterly results revealed fundamental ...